Achievements
-
.73mcourses of SP+AQ
were shipped to countries in West Africa's Sahel region in 2016, by MMV's partner Guilin Pharmaceutical, enough to provide 18 million children with Seasonal Malaria Chemoprevention
-
.Newmedicine
for children, Pyramax® granules (pyronaridine-artesunate), co-developed with Shin Poong, added to the WHO list of prequalified medicines
-
.180Pathogen Boxes
shipped free of charge to scientists around the world to boost neglected diseases drug discovery
Defeating malaria together
Featured resources
-
Investigating a second valley of death in malaria R&D
Preview of a pilot study comparing this field to funding for basic research and product development
Apr 2018 -
Defeating Malaria: Innovative Partnerships, Innovative Treatment
By Silvia Ferazzi, Advocacy Director, MMV and True Claycombe, Senior Policy Manager, Friends of the Global Fight Against AIDS, Tuberculosis and Malaria
Apr 2018 -
Efficacy and safety of fosmidomycin-piperaquine as non-artemisinin-based combination therapy for uncomplicated falciparum malaria - A single-arm, age-de-escalation proof of concept study in Gabon
Apr 2018
